Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

Introduction to Hemostasis

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...

Coagulation

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...

Extrinsic and Intrinsic Pathways of Hemostasis

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...

Disorders of Hemostasis

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Anticoagulation in patients with COVID-19].

Der Internist·2021

Same author

Higher procoagulatory potential but lower DIC score in COVID-19 ARDS patients compared to non-COVID-19 ARDS patients.

Thrombosis research·2020

Same author

The transcriptional landscape of polyploid wheat.

Science (New York, N.Y.)·2018

Same author

[Bridging anticoagulation in patients receiving vitamin K antagonists : Current status].

Der Internist·2018

Same author

[Bridging anticoagulation in patients receiving vitamin K antagonists : Current status].

Der Anaesthesist·2018

Same author

Target plasma factor levels for personalized treatment in haemophilia: a Delphi consensus statement.

Haemophilia : the official journal of the World Federation of Hemophilia·2017

Search research articles

Related Experiment Video

Updated: Jul 26, 2026

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

[Global tests of haemostasis].

M Spannagl¹, G Moessmer

¹Klinik der Universität München-Innenstadt, Ziemssenstr. 1, 80336 München. mispannagl@t-online.de

Hamostaseologie

|January 31, 2006

Summary

Global haemostasis tests are sensitive to preanalytical variables and drug effects. Strict adherence to requirements and considering influencing factors are crucial for clinically relevant conclusions.

Area of Science:

Hematology
Clinical Chemistry
Coagulation Science

Context:

Global haemostasis tests involve multiple reaction steps in blood clotting.
These tests utilize a higher proportion of plasma or whole blood compared to clotting factor tests.
Preanalytical variables, including underlying diseases and drug effects, significantly influence test outcomes.

Purpose:

To highlight the critical importance of preanalytical variables in global haemostasis testing.
To emphasize the non-comparability of results across different reagents and instrumentation, except for standardized thromboplastin time (International Normalized Ratio).
To stress the necessity of considering multiple influencing factors for accurate interpretation.

Summary:

Global haemostasis tests are highly susceptible to preanalytical influences due to their composition.

More Related Videos

Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow

Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow

Published on: March 5, 2020

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well

Published on: February 27, 2026

Related Experiment Videos

Last Updated: Jul 26, 2026

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow

Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow

Published on: March 5, 2020

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well

Published on: February 27, 2026

Standardization is limited, with only the thromboplastin time (International Normalized Ratio) being broadly comparable.

Accurate interpretation requires careful consideration of various factors and alignment with the clinical context.

Impact:

Underscores the need for strict adherence to preanalytical requirements in laboratory diagnostics.
Informs clinicians and laboratory professionals about the limitations and interpretation challenges of global haemostasis tests.
Promotes the generation of clinically relevant conclusions by ensuring laboratory requests are precisely derived from the clinical situation.